Reported 8 months ago
On June 16, 2024, Taiwan Haodin held a shareholders' meeting, coinciding with the first anniversary of CEO Dr. Wang Huijun's tenure. Dr. Wang emphasized the company's transformation and focus on ADC products and technology platform, particularly highlighting the development of the ADC platform GlycOBI™. The company also plans for a cash increase in the upcoming months to sustain development and operations.
Source: YAHOO